Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 22, 2026
AMERISAFE (AMSF) Reports +11.4% Premium Growth in Q2

AMERISAFE (AMSF) Reports +11.4% Premium Growth in Q2

Key Takeaways

  • Net premiums earned rose 11.4% year-over-year to $269.7 million.
  • Net income reached $14.6 million, or $0.78 per share.
  • Operating net income was $8.3 million, or $0.44 per share.
  • Return on average equity stood at 11.4% for the quarter.
  • Results reflect continued expansion in high-hazard workers’ compensation lines.

Why These Results Matter

AMERISAFE, Inc. specializes in workers’ compensation insurance for high-hazard industries. Its quarterly results provide insight into underwriting trends, premium pricing power, and loss ratios in a niche market. Investors track these figures closely because sustained premium growth can signal expanding demand and pricing discipline, while any shifts in loss experience directly affect profitability and capital returns in the insurance sector.

Q2 Results Breakdown

For the second quarter ended June 30, 2026, AMERISAFE reported net premiums earned of $269.7 million, an 11.4% increase from the prior-year period. Net income totaled $14.6 million, or $0.78 per diluted share. Operating net income, which excludes certain investment gains and losses, came in at $8.3 million, or $0.44 per share. The company posted a return on average equity of 11.4%.

Compared with consensus expectations, the reported net income exceeded analyst forecasts, while the operating earnings figure aligned closely with projections. Premium growth outpaced recent quarters and contributed positively to top-line momentum. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

How the Market Responded

Shares of AMERISAFE traded higher in the sessions following the July 21 release, reflecting investor focus on the solid premium expansion. Market participants viewed the results as evidence of resilient demand in the company’s specialized insurance niche, with limited negative surprises on the underwriting side.

What to Watch Going Forward

Investors will watch for updates on loss ratios and claims frequency in high-hazard industries. Continued premium growth will depend on the company’s ability to maintain pricing discipline amid competitive pressures.

Management commentary on expense management and investment income trends will help clarify margin sustainability. Broader economic conditions affecting construction, manufacturing, and energy sectors could influence future policy renewals and loss experience.

Upcoming catalysts include any revisions to full-year guidance and details from the earnings conference call regarding reserve development and capital allocation plans. From what I see, these factors will be key to assessing whether the recent momentum holds.

Using AI Tools for Deeper Analysis

In my own review of the results, I turned to Tickeron’s AI Screener to quickly compare AMERISAFE’s metrics against peers in the insurance space. The tool allowed me to filter for similar companies based on premium trends, profitability, and technical signals, which helped put the quarter into better context without spending hours on manual research. It’s become a regular part of how I evaluate specialized insurers like this one.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMSF

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AMSF in upward trend: price may jump up because it broke its lower Bollinger Band on August 17, 2026

AMSF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where AMSF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

AMSF moved below its 50-day moving average on July 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMSF crossed bearishly below the 50-day moving average on July 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMSF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AMSF entered a downward trend on August 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.929) is normal, around the industry mean (2.527). P/E Ratio (10.480) is within average values for comparable stocks, (16.925). AMSF's Dividend Yield (0.062) is considerably higher than the industry average of (0.023). P/S Ratio (1.466) is also within normal values, averaging (2.549).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AMSF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 54, placing this stock worse than average.

Industry description

Specialty insurance typically caters to niche-markets, and covers items that are special or unique and/or items that are not typically covered under other insurance policies. Restoration or purchase of a one-of-a-kind collector’s item, high-value home, recreational vehicles, sailboat or even jet skis, horses and farms, all-terrain vehicle, funerals, museums and fine art collections are some examples– one or more of which are covered by a specialty insurance provider. In some cases, a specialty insurance could also complement someone’s existing auto, home and umbrella policies. Markel Corp, for Fidelity National Financial, Inc., Assurant, Inc. and Athene Holding Ltd. are examples of specialty insurance providers.

Market Cap

The average market capitalization across the Specialty Insurance Industry is 4.47B. The market cap for tickers in the group ranges from 518.61K to 12.69B. FNF holds the highest valuation in this group at 12.69B. The lowest valued company is PMIR at 518.61K.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Insurance Industry was -2%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 1%. RYAN experienced the highest price growth at 3%, while OSG experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Specialty Insurance Industry was 5%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 46
Price Growth Rating: 57
SMR Rating: 75
Profit Risk Rating: 53
Seasonality Score: -37 (-100 ... +100)
View a ticker or compare two or three
AMSF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of workers compensation insurance for businesses in hazardous industries

Industry SpecialtyInsurance

Profile
Details
Industry
Life Or Health Insurance
Address
2301 Highway 190 West
Phone
+1 337 463-9052
Employees
370
Web
https://www.amerisafe.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
AMERISAFE (AMSF) Reports +11.4% Premium Growth in Q2